Literature DB >> 32192583

COVID-19: delay, mitigate, and communicate.

.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32192583      PMCID: PMC7118671          DOI: 10.1016/S2213-2600(20)30128-4

Source DB:  PubMed          Journal:  Lancet Respir Med        ISSN: 2213-2600            Impact factor:   30.700


× No keyword cloud information.
On March 11, 2020, WHO declared COVID-19 a pandemic and has called for governments to take “urgent and aggressive action” to change the course of the outbreak. As of March 12, 2020, the USA has suspended all travel from 26 European countries, and Italy is the latest country to enforce widespread lockdown measures to curb the spread of the virus. Robust plans and policies to avoid the disease trajectories seen in the worst-hit countries are urgently needed. These responses must be proportionate to each country's situation and communicated in a clear and balanced way to avoid spreading fear and panic. The UK preparedness plan for tackling COVID-19, informed by WHO guidance and launched on March 3, 2020, includes four phases: containment, delay, mitigation, and, alongside these, research to better understand the disease and its effects, and to address the challenges of imperfect diagnostic approaches and absence of proven treatments or a vaccine. Containment measures, aimed at preventing the disease from taking hold, are broadly in line with those of other European countries at a similar stage in the outbreak, encompassing early detection, isolation, and care of people already infected, with careful tracing and screening of their contacts. These measures might have staved off a sharp rise in cases, as seen in Italy, for now but case numbers are inevitably climbing. Although the controversial containment measures used in China have bought some time for other regions of the world, such strategies are unlikely to be replicated in Europe. The example of Singapore could be informative for many countries: having learned lessons from the severe acute respiratory syndrome epidemic of 2002–03, Singapore has so far managed the outbreak well, with rapid testing of suspected cases, clear public health messages from the outset, and by individuals taking action to protect themselves and others. With cases approaching 500, the UK has now moved to the delay phase, a decision that has been criticised for coming too late. The delay phase aims to slow the spread and push the peak impact away from the winter season to reduce pressure on an already overstretched NHS. Social distancing strategies, some of which are already in place in other European countries, such as the cancellation of conferences and other large gatherings, reducing non-essential use of public transport, and closure of schools, are under consideration but yet to be implemented in the UK. Rather, simple but important containment measures such as handwashing are being promoted, as is self-isolation for 7 days for those with symptoms, which is thought to be more effective than school closures and bans on mass gatherings. Although the list of countries imposing tight restrictions on people who have travelled from regions with high caseloads is growing, the UK is unlikely to follow suit, and WHO does not recommend large-scale international travel restrictions or closure of borders owing to the major implications for trade, international collaboration, and supply chains for food and resources, including medical equipment. Decisions about delay strategies must be scientifically based and clearly justified to the public—via all communication platforms, including social media—to counter misinformation and avoid fuelling panic. Mitigation planning for widely established infection—as seen in China, Italy, Iran, and South Korea—is essential to enable optimum care for patients, maintenance of essential hospital services, and provision of ongoing support for infected people in the community to minimise disruption to society, public services, and the economy in the event of a prolonged pandemic. The higher rates of severe or fatal cases in Italy compared with other countries with major outbreaks (eg, South Korea) might reflect the older population in affected regions of Italy and highlight the need to tailor mitigation plans to local demographics. Many health systems will be stretched beyond capacity by the demands of increasing COVID-19 caseloads. In the UK, for example, intensive care unit (ICU) bed numbers per person are already worryingly low compared with those of other European countries, so thorough surge capacity planning is needed. Interim strategies with makeshift intensive care facilities outside ICU settings could be provided to care for less severely affected patients, but such an approach would not be sustainable in the long term. Support for health-care professionals on the frontline should also be prioritised. All governments must now take decisive action to more aggressively combat the outbreak. COVID-19 represents a substantial risk to large sections of the population, and especially elderly people and those with pre-existing health conditions. As the outbreak progresses, balanced, coherent, and consistent public health communication, based on science, will be essential.
  16 in total

1.  Pharmacist's Role and Pharmaceutical Care During the COVID-19 Pandemic.

Authors:  Pedro Amariles; Mónica Ledezma-Morales; Andrea Salazar-Ospina; Jaime Alejandro Hincapié-García
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  To Zoom or not to Zoom: A longitudinal study of UK population's activities during the COVID-19 pandemic.

Authors:  Lan Li; Ava Sullivan; Anwar Musah; Katerina Stavrianaki; Caroline E Wood; Philip Baker; Patty Kostkova
Journal:  PLoS One       Date:  2022-07-13       Impact factor: 3.752

3.  Inpatient Care during the COVID-19 Pandemic: A Survey of Italian Physicians.

Authors:  Marina Attanasi; Simone Pasini; Antonio Caronni; Giulia Michela Pellegrino; Paola Faverio; Sabrina Di Pillo; Matteo Maria Cimino; Giuseppe Cipolla; Francesco Chiarelli; Stefano Centanni; Giuseppe Francesco Sferrazza Papa
Journal:  Respiration       Date:  2020-08-05       Impact factor: 3.580

4.  The common personal behavior and preventive measures among 42 uninfected travelers from the Hubei province, China during COVID-19 outbreak: a cross-sectional survey in Macao SAR, China.

Authors:  Chon Fu Lio; Hou Hon Cheong; Chin Ion Lei; Iek Long Lo; Lan Yao; Chong Lam; Iek Hou Leong
Journal:  PeerJ       Date:  2020-06-19       Impact factor: 2.984

Review 5.  The COVID-19 epidemic, its mortality, and the role of non-pharmaceutical interventions.

Authors:  Niel Hens; Pascal Vranck; Geert Molenberghs
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2020-04-30

6.  Infectious diseases epidemiology, quantitative methodology, and clinical research in the midst of the COVID-19 pandemic: Perspective from a European country.

Authors:  Geert Molenberghs; Marc Buyse; Steven Abrams; Niel Hens; Philippe Beutels; Christel Faes; Geert Verbeke; Pierre Van Damme; Herman Goossens; Thomas Neyens; Sereina Herzog; Heidi Theeten; Koen Pepermans; Ariel Alonso Abad; Ingrid Van Keilegom; Niko Speybroeck; Catherine Legrand; Stefanie De Buyser; Frank Hulstaert
Journal:  Contemp Clin Trials       Date:  2020-10-22       Impact factor: 2.226

7.  A cross-sectional survey on community pharmacists readiness to fight COVID-19 in a developing country: knowledge, attitude, and practice in Lebanon.

Authors:  Rony M Zeenny; Ahmad Dimassi; Hala Sacre; Ghada El Khoury; Aline Hajj; Rita Farah; Hind Hajj; Nathalie Lahoud; Marwan Akel; Souheil Hallit; Pascale Salameh
Journal:  J Pharm Policy Pract       Date:  2021-06-11

8.  Provision of community pharmacy services during COVID-19 pandemic: a cross sectional study of community pharmacists' experiences with preventative measures and sources of information.

Authors:  Kreshnik Hoti; Arianit Jakupi; Dardan Hetemi; Denis Raka; Jeffery Hughes; Shane Desselle
Journal:  Int J Clin Pharm       Date:  2020-06-11

9.  COVID-19: Utilizing local experience to suggest optimal global strategies to prevent and control the pandemic.

Authors:  Ilias Mahmud; Abdulrahman Al-Mohaimeed
Journal:  Int J Health Sci (Qassim)       Date:  2020 May-Jun

10.  Impact of COVID-19 on Pharmaceutical Care Services and the Role of Community Pharmacists: A Multi-Center Cross-Sectional Study in Ethiopia.

Authors:  Dawit Kumilachew Yimenu; Chilot Abiyu Demeke; Asmamaw Emagn Kasahun; Ebrahim Abdela Siraj; Adane Yehualaw Wendalem; Zegaye Agmassie Bazezew; Abebe Basazn Mekuria
Journal:  SAGE Open Nurs       Date:  2021-06-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.